Table 2

Price and price differential between prescriptions for pensioners and non-pensioners by pharmacological group.

Copayment

DDD/1000/year

Price month

Price

%


Pensioners

Non-pensioners

Pensioners

Non-pensioners

Diff.

Areas


Cardiovascular groups


Beta-blockers

RC

46.08

6.12

9.72

8.78

0.90

80.00


ACEIs & ARBs

RC

326.47

29.99

14.34

13.81

0.54

68.57


Diuretics

RC

113.47

6.74

5.66

5.40

0.26

41.43


Nitrates

RC

53.21

0.82

11.90

12.02

-0.12

40.00


Ca++channel blockers

RC

109.35

6.73

17.85

15.89

1.96

98.57


Antiplatelet drugs

FC

98.74

4.96

14.34

11.45

2.89

94.29


Flavonoids

FC

44.06

3.45

7.95

8.46

0.50

50.00


Statines

FC

187.18

17.70

19.84

18.29

1.54

98.57


Psychotropic drugs


SSRIs

RC

98.72

21.99

26.32

26.11

0.21

34.38


Typical antipsych.

RC

5.35

0.25

8.61

8.82

-0.21

39.58


Atypical antipsych.

RC

18.71

2.23

125.24

130.57

-5.33

18.75


MAOIs

RC

0.10

0.02

15.79

14.43

1.35

42.71


Lithium

RC

1.02

0.28

5.62

5.80

-0.18

52.08


Anti-dementia

FC

18.40

0.19

82.18

27.99

54.18

100.00


Hypnotics

FC

69.04

6.04

3.20

3.05

0.14

84.38


Anxiolytics

FC

124.34

19.66

4.46

4.74

-0.28

6.24


Stimulants

FC

0.53

0.61

57.78

52.86

4.92

76.04


ACEI: angiotensin-converting enzyme inhibitors; ARB: angiotensin receptor blockers; SSRIs: Selective Serotonin Reuptake Inhibitors; MAOIs: Monoamine oxidase inhibitors. Copayment: FC if non-pensioners pay a copayment of 40%, RC if non-pensioners pay a reduced co-payment of 10% with a ceiling of €2.64; DDD/1000/year: Daily defined doses dispensed per 1000 people and year; Price: cost of one month of treatment; Price differences: between the monthly cost of treatment between pensioners and non-pensioners; % areas: % of areas with monthly costs of treatment higher in pensioners than in non-pensioners.

González López-Valcárcel et al. BMC Health Services Research 2011 11:333   doi:10.1186/1472-6963-11-333

Open Data